Skip to main content
Top
Published in: International Urology and Nephrology 6/2016

01-06-2016 | Nephrology - Original Paper

The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS)

Authors: Motohiro Shimizu, Norihiro Furusyo, Yuuki Tanaka, Yoshifumi Kato, Fujiko Mitsumoto-Kaseida, Koji Takayama, Kazuya Ura, Satoshi Hiramine, Takeo Hayashi, Hiroaki Ikezaki, Takeshi Ihara, Haru Mukae, Eiichi Ogawa, Kazuhiro Toyoda, Mosaburo Kainuma, Masayuki Murata, Jun Hayashi

Published in: International Urology and Nephrology | Issue 6/2016

Login to get access

Abstract

Background

Previous clinical studies have shown that the circulating level of endostatin is related to kidney injury. We hypothesized that the impact of HbA1c, fasting, and postprandial plasma glucose on urinary albumin excretion would be related to the serum endostatin level.

Methods

A cross-sectional, community-based population study of 1057 Japanese residents was conducted. Of these subjects, 162 with a fasting plasma glucose value between 5.5 and 6.9 mmol/L and an HbA1c level of <6.5 % received an oral glucose tolerance test, had serum endostatin measured, and had the urinary albumin/creatinine ratio (UACR) calculated.

Results

In multivariate analysis, 2-h postprandial plasma glucose (β = 0.26, P < 0.01) was significantly associated with log-transformed UACR, independently of fasting plasma glucose (β = 0.14, P = 0.28) and HbA1c (β = −0.08, P = 0.57). When divided by the median value of endostatin (82.2 ng/mL), 2-h postprandial plasma glucose (β = 0.38, P = 0.01) remained significantly associated with the log-transformed UACR of the participants below the median, while the fasting plasma glucose (β = 0.34, P = 0.046) was independently associated with the log-transformed UACR of participants above the median.

Conclusion

Postprandial plasma glucose was independently associated with the urinary albumin excretion of the residents with prediabetes. Moreover, this relationship was limited to residents with a serum endostatin level below the median.
Literature
1.
go back to reference Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127–1133CrossRefPubMed Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127–1133CrossRefPubMed
2.
go back to reference de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305:2532–2539CrossRefPubMedPubMedCentral de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305:2532–2539CrossRefPubMedPubMedCentral
3.
go back to reference Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed
4.
go back to reference Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O’Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–430CrossRefPubMedPubMedCentral Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O’Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–430CrossRefPubMedPubMedCentral
6.
go back to reference Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y (2005) Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 336:339–345CrossRefPubMed Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y (2005) Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 336:339–345CrossRefPubMed
7.
go back to reference Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ (1993) Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity. Diabetes Care 16:1485–1493CrossRefPubMed Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ (1993) Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity. Diabetes Care 16:1485–1493CrossRefPubMed
8.
go back to reference Muris DM, Houben AJ, Schram MT, Stehouwer CD (2012) Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 32:3082–3094CrossRefPubMed Muris DM, Houben AJ, Schram MT, Stehouwer CD (2012) Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 32:3082–3094CrossRefPubMed
9.
go back to reference Beck-Nielsen H, Groop LC (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714–1721CrossRefPubMedPubMedCentral Beck-Nielsen H, Groop LC (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714–1721CrossRefPubMedPubMedCentral
10.
go back to reference Monnier L, Colette C, Dunseath GJ, Owens DR (2007) The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30:263–269CrossRefPubMed Monnier L, Colette C, Dunseath GJ, Owens DR (2007) The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30:263–269CrossRefPubMed
11.
go back to reference Seppinen L, Pihlajaniemi T (2011) The multiple functions of collagen XVIII in development and disease. Matrix Biol 30:83–92CrossRefPubMed Seppinen L, Pihlajaniemi T (2011) The multiple functions of collagen XVIII in development and disease. Matrix Biol 30:83–92CrossRefPubMed
12.
go back to reference Arnlov J, Ruge T, Ingelsson E, Larsson A, Sundstrom J, Lind L (2013) Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts. Arterioscler Thromb Vasc Biol 33:2689–2695CrossRefPubMed Arnlov J, Ruge T, Ingelsson E, Larsson A, Sundstrom J, Lind L (2013) Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts. Arterioscler Thromb Vasc Biol 33:2689–2695CrossRefPubMed
13.
go back to reference Ruge T, Carlsson AC, Larsson TE, Carrero JJ, Larsson A, Lind L, Arnlov J (2014) Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts. Am J Nephrol 40:417–424CrossRefPubMed Ruge T, Carlsson AC, Larsson TE, Carrero JJ, Larsson A, Lind L, Arnlov J (2014) Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts. Am J Nephrol 40:417–424CrossRefPubMed
14.
go back to reference Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35:335–340CrossRefPubMedPubMedCentral Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35:335–340CrossRefPubMedPubMedCentral
15.
go back to reference Carlsson AC, Ruge T, Sundstrom J, Ingelsson E, Larsson A, Lind L, Arnlov J (2013) Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension 62:1146–1151CrossRefPubMed Carlsson AC, Ruge T, Sundstrom J, Ingelsson E, Larsson A, Lind L, Arnlov J (2013) Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension 62:1146–1151CrossRefPubMed
16.
go back to reference Watorek E, Paprocka M, Dus D, Kopec W, Klinger M (2011) Endostatin and vascular endothelial growth factor: potential regulators of endothelial progenitor cell number in chronic kidney disease. Pol Arch Med Wewn 121:296–301PubMed Watorek E, Paprocka M, Dus D, Kopec W, Klinger M (2011) Endostatin and vascular endothelial growth factor: potential regulators of endothelial progenitor cell number in chronic kidney disease. Pol Arch Med Wewn 121:296–301PubMed
17.
go back to reference Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM (2014) Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. Int J Cardiol 176:99–109CrossRefPubMedPubMedCentral Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM (2014) Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. Int J Cardiol 176:99–109CrossRefPubMedPubMedCentral
18.
go back to reference Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J (2015) Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis 238:207–212CrossRefPubMed Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J (2015) Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis 238:207–212CrossRefPubMed
19.
go back to reference Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J (2014) The utility of urinary myo-inositol as a marker of glucose intolerance. Diabetes Res Clin Pract 103:88–96CrossRefPubMed Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J (2014) The utility of urinary myo-inositol as a marker of glucose intolerance. Diabetes Res Clin Pract 103:88–96CrossRefPubMed
20.
go back to reference Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 17:751–758CrossRefPubMed Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 17:751–758CrossRefPubMed
21.
go back to reference Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2011) Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese Population Study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 54:3028–3036CrossRefPubMed Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2011) Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese Population Study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 54:3028–3036CrossRefPubMed
22.
go back to reference Unno M, Furusyo N, Mukae H, Koga T, Eiraku K, Hayashi J (2012) The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome - the results of the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 19:462–470CrossRefPubMed Unno M, Furusyo N, Mukae H, Koga T, Eiraku K, Hayashi J (2012) The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome - the results of the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 19:462–470CrossRefPubMed
23.
go back to reference Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2013) Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol 167:2066–2072CrossRefPubMed Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2013) Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol 167:2066–2072CrossRefPubMed
24.
go back to reference Ihara T, Furusyo N, Hayashi T, Toyoda K, Murata M, Hayashi J (2013) A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS). Arch Virol 158:2465–2472CrossRefPubMed Ihara T, Furusyo N, Hayashi T, Toyoda K, Murata M, Hayashi J (2013) A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS). Arch Virol 158:2465–2472CrossRefPubMed
25.
go back to reference Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J (2013) Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis 231:238–245CrossRefPubMed Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J (2013) Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis 231:238–245CrossRefPubMed
26.
go back to reference Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J (2015) Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. Metabolism 64:698–705CrossRefPubMed Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J (2015) Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. Metabolism 64:698–705CrossRefPubMed
27.
go back to reference Coleman A, Steel S, Freeman P, de Greeff A, Shennan A (2008) Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit 13:49–54CrossRefPubMed Coleman A, Steel S, Freeman P, de Greeff A, Shennan A (2008) Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit 13:49–54CrossRefPubMed
28.
go back to reference American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1):S64–71CrossRef American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1):S64–71CrossRef
29.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
30.
go back to reference Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687CrossRefPubMed Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687CrossRefPubMed
31.
go back to reference Xu YZ, Zhang X, Wang L, Zhang F, Qiu Q, Liu ML, Zhang GR, Wu XL (2013) An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Intern Med 52:855–861CrossRefPubMed Xu YZ, Zhang X, Wang L, Zhang F, Qiu Q, Liu ML, Zhang GR, Wu XL (2013) An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Intern Med 52:855–861CrossRefPubMed
32.
go back to reference Li SY, Huang PH, Yang AH, Tarng DC, Yang WC, Lin CC, Chen JW, Schmid-Schonbein G, Lin SJ (2014) Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int 86:358–369CrossRefPubMed Li SY, Huang PH, Yang AH, Tarng DC, Yang WC, Lin CC, Chen JW, Schmid-Schonbein G, Lin SJ (2014) Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int 86:358–369CrossRefPubMed
33.
go back to reference Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD (2015) Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol 14:31CrossRefPubMedPubMedCentral Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD (2015) Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol 14:31CrossRefPubMedPubMedCentral
34.
go back to reference Tanaka S, Takase H, Dohi Y, Kimura G (2013) The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Res Notes 6:256CrossRefPubMedPubMedCentral Tanaka S, Takase H, Dohi Y, Kimura G (2013) The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Res Notes 6:256CrossRefPubMedPubMedCentral
35.
go back to reference Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, Rhee BD, Kim DJ (2013) Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS ONE 8:e83273CrossRefPubMedPubMedCentral Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, Rhee BD, Kim DJ (2013) Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS ONE 8:e83273CrossRefPubMedPubMedCentral
36.
go back to reference Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP (2007) High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study. Diabet Med 24:1136–1142CrossRefPubMed Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP (2007) High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study. Diabet Med 24:1136–1142CrossRefPubMed
Metadata
Title
The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS)
Authors
Motohiro Shimizu
Norihiro Furusyo
Yuuki Tanaka
Yoshifumi Kato
Fujiko Mitsumoto-Kaseida
Koji Takayama
Kazuya Ura
Satoshi Hiramine
Takeo Hayashi
Hiroaki Ikezaki
Takeshi Ihara
Haru Mukae
Eiichi Ogawa
Kazuhiro Toyoda
Mosaburo Kainuma
Masayuki Murata
Jun Hayashi
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1258-3

Other articles of this Issue 6/2016

International Urology and Nephrology 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine